UZ Gent-Reuma
Gent, East Flanders, Belgium
University hospital in Ghent
Corneel Heymanslaan 10, 9000 Gent
About UZ Gent-Reuma
Ghent University Hospital is one of the largest hospitals in Belgium. It is closely linked to Ghent University, the university's rector also being the hospital's president. Both the university and the hospital are autonomous entities of the Flemish Government.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Rheumazentrum Ruhrgebiet
2
Clinical Trials at UZ Gent-Reuma
During the past decade, UZ Gent-Reuma conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
2005-12-01
2011-04-01
Unknown status
149
European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
2011-02-01
2013-10-01
Unknown status
100
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
2019-04-05
2030-12-18
Recruiting
190
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
2018-12-17
2022-01-26
Completed
220
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA
2020-02-12
2023-08-07
Recruiting
103
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
2021-04-13
2028-04-24
Recruiting
100
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Gent-Reuma"
#1 collaborator was "Centocor BV" with 1 trials as a collaborator, "Centocor Ortho Biotech Services, L.L.C." with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Trial Coordination Center, 9713 GZ Groningen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at UZ Gent-Reuma
According to Clinical.Site data, the most researched conditions in "UZ Gent-Reuma" are
"Ankylosing Spondylitis" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Enthesitis Related Arthritis" (1 trials), "Juvenile Psoriatic Arthritis" (1 trials) and "Systemic Juvenile Idiopathic Arthritis" (1 trials). Many other conditions were trialed in "UZ Gent-Reuma" in a lesser frequency.
Clinical Trials Intervention Types at UZ Gent-Reuma
Most popular intervention types in "UZ Gent-Reuma" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Baricitinib" (3 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "Ixekizumab" (1 trials) and "infliximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UZ Gent-Reuma
The vast majority of trials in "UZ Gent-Reuma" are
6 trials for "All" genders.
Clinical Trials Status at UZ Gent-Reuma
Currently, there are NaN active trials in "UZ Gent-Reuma".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in UZ Gent-Reuma,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UZ Gent-Reuma, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".